PRGO
Perrigo Company plc
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+27/100
Last price
14.00
▼ 0.44 (3.05%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
14.44
Day high
14.63
Day low
13.91
Volume
2.04M
Market cap
$1.94B
P/E (TTM)
—
52W range
9.23 – 22.02
Trailing performance
Returnvs SPY
1W
-6.67%
-8.6%
1M
-6.17%
-7.3%
3M
+33.08%
+28.6%
6M
+32.58%
+14.4%
YTD
+0.57%
-13.7%
1Y
-37.81%
-54.2%
3Y
-56.18%
-138.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PRGO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
545.36K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 11, 26 | ALFORD BRADLEY A Director |
CONVERSION | 1.26K | $17.25K | Direct |
| Sep 11, 26 | PARKER GEOFFREY M Director |
CONVERSION | 1.26K | $17.25K | Direct |
| Sep 9, 26 | BALL DAVID Officer |
CONVERSION | 7.70K | $110.43K | Direct |
| Jul 8, 26 | KHOURY ROBERTO Officer |
CONVERSION | 737 | $7.75K | Direct |
| Jul 8, 26 | WINTERMAN MATTHEW JOHN Officer |
CONVERSION | 17.50K | $184.13K | Direct |
| Jun 12, 26 | ALFORD BRADLEY A Director |
— | 976 | — | Direct |
| Jun 12, 26 | PARKER GEOFFREY M Director |
CONVERSION | 976 | $10.73K | Direct |
| Jun 5, 26 | BEZERRA EDUARDO GUARITA Chief Financial Officer |
CONVERSION | 9.18K | $99.36K | Direct |
| Jun 5, 26 | WILLIS ROBERT Officer |
— | 3.44K | — | Direct |
| Jun 5, 26 | LOCKWOOD-TAYLOR PATRICK Former |
CONVERSION | 25.23K | $273.24K | Direct |
| Jun 5, 26 | KHOURY ROBERTO Officer |
CONVERSION | 17.90K | $193.88K | Direct |
| Jun 5, 26 | BALL DAVID Officer |
— | 2.87K | — | Direct |
| Jun 5, 26 | ATKINSON CHARLES General Counsel |
CONVERSION | 6.69K | $72.45K | Direct |
| Jun 5, 26 | LENNOX ABIGAIL Officer |
— | 3.82K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALFORD BRADLEY A |
Director | 46.12K | Conversion of Exercise of derivative security |
ASHFORD ORLANDO D |
Director | 27.72K | Conversion of Exercise of derivative security |
BEZERRA EDUARDO GUARITA |
Chief Financial Officer | 84.70K | Conversion of Exercise of derivative security |
JANISH RONALD CRAIG |
Chief Technology Officer | 35.56K | Conversion of Exercise of derivative security |
KARABOUTIS ADRIANA |
Director | 27.63K | Conversion of Exercise of derivative security |
LOCKWOOD-TAYLOR PATRICK |
Former | 123.17K | Conversion of Exercise of derivative security |
MANZONE ALBERT |
Director | 16.35K | Conversion of Exercise of derivative security |
O'CONNOR DONAL |
Director | 35.63K | Conversion of Exercise of derivative security |
PARKER GEOFFREY M |
Director | 77.13K | Conversion of Exercise of derivative security |
WILLIS ROBERT |
Officer | 50.57K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.94B
Enterprise value$5.02B
Revenue (TTM)$4.14B
Gross profit$1.38B
EBITDA$615.50M
Net income$-1.70B
EPS (TTM)$-12.28
Free cash flow$437.21M
Total cash$399.70M
Total debt$3.48B
Book value / share$18.14
Shares outstanding138.37M
Float138.07M
Short % of float25.02%
Dividend yield8.29%
Beta (5Y)0.69
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.84
PEG ratio1.14
Price / sales—
Price / book0.77
EV / revenue1.21
EV / EBITDA8.16
Gross margin33.26%
Operating margin3.84%
Profit margin-41.85%
Return on equity-48.75%
Return on assets1.97%
Debt / equity138.18
Current ratio2.32
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.25B | $4.37B | $4.66B | $4.45B | -2.8% |
| Operating revenue | $4.25B | $4.37B | $4.66B | $4.45B | -2.8% |
| Cost of revenue | $2.76B | $2.83B | $2.98B | $3.00B | -2.5% |
| Gross profit | $1.49B | $1.54B | $1.68B | $1.46B | -3.1% |
| Research & development | $95.40M | $112.20M | $122.50M | $123.10M | -15.0% |
| Selling, general & admin | $1.06B | $1.11B | $1.27B | $1.21B | -5.1% |
| Total operating expense | $1.18B | $1.23B | $1.40B | $1.33B | -4.0% |
| Operating income | $312.80M | $311.90M | $284.10M | $121.40M | +0.3% |
| Net interest income | -$162.50M | -$187.80M | -$173.80M | -$156.00M | +13.5% |
| Pre-tax income | -$1.30B | -$80.70M | -$8.30M | -$139.10M | -1,508.3% |
| Tax provision | $104.40M | $80.00M | -$3.90M | -$8.20M | +30.5% |
| Net income | -$1.43B | -$171.80M | -$12.70M | -$140.60M | -729.7% |
| Net income to common | -$1.43B | -$171.80M | -$12.70M | -$140.60M | -729.7% |
| Basic EPS | -10.29 | -1.25 | -0.09 | -1.04 | -723.2% |
| Diluted EPS | -10.29 | -1.25 | -0.09 | -1.04 | -723.2% |
| EBIT | -$1.14B | $107.10M | $165.50M | $16.90M | -1,160.1% |
| EBITDA | -$797.90M | $433.00M | $525.00M | $355.50M | -284.3% |
| Basic shares | 138.50M | 137.40M | 135.30M | 134.50M | +0.8% |
| Diluted shares | 138.50M | 137.40M | 135.30M | 134.50M | +0.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $531.60M | $558.80M | $751.30M | $600.70M | -4.9% |
| Cash & short-term investments | $531.60M | $558.80M | $751.30M | $600.70M | -4.9% |
| Accounts receivable | $612.80M | $642.30M | $739.60M | $697.10M | -4.6% |
| Inventory | $1.15B | $1.08B | $1.14B | $1.15B | +6.2% |
| Total current assets | $2.80B | $2.48B | $2.83B | $2.72B | +12.7% |
| Property, plant & equipment | $1.07B | $1.09B | $1.10B | $1.14B | -2.4% |
| Goodwill & intangibles | $4.41B | $5.75B | $6.52B | $6.78B | -23.4% |
| Total assets | $8.54B | $9.65B | $10.81B | $11.02B | -11.5% |
| Total current liabilities | $1.01B | $1.04B | $1.59B | $1.11B | -3.0% |
| Current debt | $36.60M | $36.40M | $440.60M | $36.20M | +0.5% |
| Long-term debt | $3.60B | $3.58B | $3.63B | $4.07B | +0.6% |
| Total debt | $3.64B | $3.62B | $4.07B | $4.11B | +0.6% |
| Total liabilities | $5.60B | $5.33B | $6.04B | $6.18B | +5.1% |
| Retained earnings | -$3.68B | -$2.25B | -$2.08B | -$2.07B | -63.3% |
| Shareholder equity | $2.94B | $4.32B | $4.77B | $4.84B | -32.0% |
| Working capital | $1.78B | $1.44B | $1.25B | $1.61B | +24.1% |
| Net tangible assets | -$1.47B | -$1.43B | -$1.75B | -$1.94B | -2.9% |
| Shares issued | 137.62M | 136.43M | 135.51M | 134.70M | +0.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.43B | -$171.80M | -$12.70M | -$140.60M | — | -729.7% |
| Depreciation & amortisation | $337.50M | $325.90M | $359.50M | $338.60M | — | +3.6% |
| Stock-based compensation | $54.60M | $64.40M | $68.80M | $54.90M | — | -15.2% |
| Change in working capital | -$101.10M | -$74.70M | -$58.50M | $20.00M | — | -35.3% |
| Operating cash flow | $238.50M | $362.90M | $405.50M | $307.30M | — | -34.3% |
| Capital expenditure | -$93.40M | -$118.30M | -$101.70M | -$96.40M | — | +21.0% |
| Investing cash flow | -$75.40M | $78.80M | -$77.50M | -$1.96B | — | -195.7% |
| Share buybacks | — | — | — | $0 | $0 | — |
| Dividends paid | -$159.30M | -$152.50M | -$149.70M | -$142.40M | — | -4.5% |
| Financing cash flow | -$220.50M | -$611.00M | -$187.20M | $421.60M | — | +63.9% |
| Free cash flow | $145.10M | $244.60M | $303.80M | $210.90M | — | -40.7% |
| End cash position | $531.60M | $558.80M | $751.30M | $600.70M | — | -4.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.02B | $969.20M | $1.11B | $1.04B | $1.06B | +5.5% |
| Operating revenue | $1.02B | $969.20M | $1.11B | $1.04B | $1.06B | +5.5% |
| Cost of revenue | $708.90M | $643.70M | $747.40M | $666.20M | $693.40M | +10.1% |
| Gross profit | $313.90M | $325.50M | $362.20M | $377.10M | $362.90M | -3.6% |
| Research & development | $23.70M | $24.60M | $21.80M | $24.90M | $22.00M | -3.7% |
| Selling, general & admin | $251.20M | $267.30M | $255.90M | $245.70M | $273.10M | -6.0% |
| Total operating expense | $274.90M | $291.90M | $277.80M | $283.70M | $307.30M | -5.8% |
| Operating income | $39.00M | $33.60M | $84.40M | $93.40M | $55.60M | +16.1% |
| Net interest income | -$38.40M | -$40.80M | -$43.30M | -$40.60M | -$39.60M | +5.9% |
| Pre-tax income | $105.40M | -$408.50M | -$1.33B | $22.40M | $3.20M | +125.8% |
| Tax provision | $16.90M | -$18.70M | $82.90M | $9.70M | $3.70M | +190.4% |
| Net income | $74.50M | -$398.60M | -$1.42B | $7.50M | -$8.40M | +118.7% |
| Net income to common | $74.50M | -$398.60M | -$1.42B | $7.50M | -$8.40M | +118.7% |
| Basic EPS | 0.54 | -2.87 | -10.22 | 0.05 | -0.06 | +118.8% |
| Diluted EPS | 0.53 | -2.87 | -10.22 | 0.05 | -0.06 | +118.5% |
| EBIT | $143.80M | -$367.70M | -$1.29B | $63.00M | $42.80M | +139.1% |
| EBITDA | $239.60M | -$284.40M | -$1.20B | $148.40M | $129.10M | +184.2% |
| Basic shares | 139.10M | 138.70M | 138.70M | 138.50M | 138.20M | +0.3% |
| Diluted shares | 139.60M | 138.70M | 138.70M | 138.90M | 138.20M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $399.70M | $357.20M | $531.60M | $432.10M | $454.20M | +11.9% |
| Cash & short-term investments | $399.70M | $357.20M | $531.60M | $432.10M | $454.20M | +11.9% |
| Accounts receivable | $709.90M | $697.10M | $612.80M | $644.40M | $678.20M | +1.8% |
| Inventory | $1.06B | $1.12B | $1.15B | $1.23B | $1.22B | -5.1% |
| Total current assets | $2.45B | $2.71B | $2.80B | $2.88B | $2.62B | -9.6% |
| Property, plant & equipment | $1.00B | $1.04B | $1.07B | $1.07B | $1.09B | -3.4% |
| Goodwill & intangibles | $3.89B | $3.97B | $4.41B | $5.77B | $6.04B | -2.0% |
| Total assets | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | -4.7% |
| Total current liabilities | $1.05B | $997.60M | $1.01B | $1.15B | $1.13B | +5.7% |
| Current debt | $11.40M | $11.40M | $36.60M | $36.60M | $36.40M | 0.0% |
| Long-term debt | $3.28B | $3.62B | $3.60B | $3.61B | $3.62B | -9.3% |
| Total debt | $3.29B | $3.63B | $3.64B | $3.64B | $3.65B | -9.3% |
| Total liabilities | $5.09B | $5.48B | $5.60B | $5.64B | $5.62B | -7.1% |
| Retained earnings | -$4.00B | -$4.08B | -$3.68B | -$2.26B | -$2.27B | +1.8% |
| Shareholder equity | $2.52B | $2.50B | $2.94B | $4.45B | $4.47B | +0.7% |
| Working capital | $1.40B | $1.71B | $1.78B | $1.73B | $1.49B | -18.5% |
| Net tangible assets | -$1.37B | -$1.47B | -$1.47B | -$1.32B | -$1.57B | +6.4% |
| Shares issued | 138.70M | 138.10M | 137.62M | 137.58M | 137.60M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $74.50M | -$398.60M | -$1.42B | $7.50M | -$8.40M | +118.7% |
| Depreciation & amortisation | $95.80M | $83.30M | $85.90M | $85.40M | $86.30M | +15.0% |
| Stock-based compensation | $6.80M | $14.40M | $13.00M | $13.20M | $16.80M | -52.8% |
| Change in working capital | $35.90M | -$196.30M | $158.80M | -$47.70M | -$32.80M | +118.3% |
| Operating cash flow | $82.60M | -$113.60M | $175.40M | $51.70M | $75.90M | +172.7% |
| Capital expenditure | -$14.30M | -$13.80M | -$26.80M | -$21.90M | -$19.20M | -3.6% |
| Investing cash flow | $349.40M | -$12.40M | -$24.50M | -$21.40M | -$3.80M | +2,917.7% |
| Dividends paid | -$40.20M | -$39.90M | -$39.90M | -$39.90M | -$38.90M | -0.8% |
| Financing cash flow | -$388.90M | -$45.30M | -$54.40M | -$50.30M | -$54.00M | -758.5% |
| Free cash flow | $68.30M | -$127.40M | $148.60M | $29.80M | $56.70M | +153.6% |
| End cash position | $399.70M | $357.20M | $531.60M | $432.10M | $454.20M | +11.9% |
Options analytics
Put / call volume
0.57
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
-82.1% from spot
ATM implied vol
12.5%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
23
Contracts, this expiry
Put volume
13
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
12.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.36 | 0.50 | +40.8% |
| Mar 2026 | 0.31 | 0.43 | +40.2% |
| Dec 2025 | 0.78 | 0.77 | -1.3% |
| Sep 2025 | 0.77 | 0.80 | +3.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.53 | 4 | $999.15M | -4.2% |
| Next quarter | 0.74 | 4 | $1.07B | -3.7% |
| Current year | 2.19 | 5 | $4.06B | -4.6% |
| Next year | 2.40 | 5 | $4.09B | +0.7% |
Analyst targets & ownership
Mean target$16.50
High target$20.00
Low target$14.00
Implied upside17.86%
Analyst count4
ConsensusNONE
Strong buy / Buy1 / 1
Hold3
Sell / Strong sell0 / 0
Held by insiders0.39%
Held by institutions115.42%
Institutions holding440
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.55
-3.79% from price
SMA 20
14.17
-1.18% from price
SMA 50
13.52
+3.54% from price
SMA 100
12.05
+16.14% from price
SMA 200
12.30
+13.82% from price
EMA 12
14.35
-2.45% from price
EMA 26
14.12
-0.87% from price
EMA 50
13.53
+3.49% from price
RSI (14)
48.9
Neutral
MACD (12,26,9)
0.23
Hist -0.09
ATR (14)
0.69
4.94% of price
Realised vol 30D
42.4%
Annualised
Bollinger upper
15.31
20, 2σ
Bollinger lower
13.03
20, 2σ
50 / 200 cross
Golden
13.52 vs 12.30
Trend bias
Above 200
+13.82%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.06
More volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
42.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-58.0%
Peak to trough
Max drawdown 5Y
-80.7%
Peak to trough
ATR 14
0.69
4.94% of price
Beta (reported)
0.69
5Y monthly, from filing
Short interest
Shares short
22.64M
Prior 22.18M
Change vs prior
+2.1%
Shorts adding
% of float
25.02%
Heavily shorted
% of shares out
16.31%
Against total outstanding
Days to cover
9.2
Crowded exit
Float
138.07M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 27, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Dec 15, 25 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Nov 6, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Nov 6, 25 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Oct 27, 25 | Jefferies | MAINTAINED | Hold | Hold |
| Aug 7, 25 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 7, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jan 6, 25 | Piper Sandler | DOWNGRADE | Overweight | Neutral |
| Sep 30, 24 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Sep 23, 24 | Jefferies | DOWNGRADE | Buy | Hold |
| Jul 11, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jun 13, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$1.16 / yr
Forward yield8.29%
5-year avg yield3.70%
Payout ratio1348.75%
Ex-dividend dateAug 28, 2026
Next pay dateSep 15, 2026
Last split2:1
Split dateAug 26, 1993
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-06
Corporate Changes & Voting Matters
8-K · 2026-06-30
Annual report of employee stock purchase
11-K · 2026-06-24
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-12
Corporate Changes & Voting Matters
8-K · 2026-06-08
Periodic Financial Reports
10-Q · 2026-05-06
Offering Registrations
S-8 · 2026-05-05
Headlines
Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Zacks · 12d ago
Perrigo (PRGO) Up 13.8% Since Last Earnings Report: Can It Continue?
Zacks · 33d ago
Perrigo to Attend the Barclays Global Consumer Conference
PR Newswire · 41d ago
PRGO or NEOG: Which Is the Better Value Stock Right Now?
Zacks · 42d ago
Should Value Investors Buy Perrigo (PRGO) Stock?
Zacks · 42d ago
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
Motley Fool · 45d ago
Perrigo (PRGO) Q2 2026 Earnings Call Transcript
Motley Fool · 56d ago
PRGO vs. NEOG: Which Stock Is the Better Value Option?
Zacks · 58d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.